Curated News
By: NewsRamp Editorial Staff
June 17, 2026
Cardio Diagnostics Takes Heart Health to Benefits Conferences
TLDR
- Cardio Diagnostics helps employers cut healthcare costs by identifying cardiovascular risk earlier, reducing lost productivity and long-term expenses.
- Cardio Diagnostics uses targeted risk assessment and preventive care solutions to identify cardiovascular issues earlier, enabling cost-effective interventions.
- By preventing heart attacks through earlier risk detection, Cardio Diagnostics improves patient outcomes and reduces suffering for families and communities.
- Cardiovascular disease accounts for 11% of US healthcare spending, more than any major diagnostic group, driving innovation in prevention.
Impact - Why it Matters
This matters because cardiovascular disease is the most expensive health condition in the US, accounting for 11% of healthcare expenditures. By engaging benefits decision-makers, Cardio Diagnostics could help employers and insurers reduce costs and improve employee health through earlier risk detection and preventive care.
Summary
LOS ANGELES, CA - A single heart attack or major cardiovascular event can have consequences that extend far beyond a patient’s health, affecting employers, insurers and healthcare systems through higher medical costs, lost productivity and long-term care expenses. As cardiovascular disease continues to drive a significant share of healthcare spending, organizations responsible for employee benefits are seeking new strategies to identify risk earlier and improve outcomes. Cardio Diagnostics Holdings (NASDAQ: CDIO) is engaging directly with these stakeholders at four national benefits conferences in June, where the company plans to discuss innovative approaches to cardiovascular disease prevention, risk assessment and cost management.
According to the American Heart Association (“AHA”), cardiovascular disease remains one of the most expensive health conditions in the United States. Direct cardiovascular healthcare costs accounted for approximately 11% of all U.S. healthcare expenditures in 2020–2021, more than any major diagnostic group. The company has developed a suite of solutions designed to provide earlier identification of cardiovascular risk and enable more targeted interventions and preventive care. By addressing the root of the problem before a major event occurs, Cardio Diagnostics aims to reduce the financial burden on employers and insurers while improving patient outcomes.
The company’s participation in these conferences underscores a growing trend among benefits decision-makers to prioritize preventive health measures. With healthcare costs continuing to rise, the ability to predict and prevent cardiovascular events could lead to significant savings and healthier workforces. The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, Cardio Diagnostics Takes Heart Health to Benefits Conferences
